D.A. Davidson & CO. Purchases 8,585 Shares of GE HealthCare Technologies Inc. $GEHC

D.A. Davidson & CO. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 155.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,124 shares of the company’s stock after buying an additional 8,585 shares during the period. D.A. Davidson & CO.’s holdings in GE HealthCare Technologies were worth $1,061,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. True North Advisors LLC boosted its holdings in GE HealthCare Technologies by 2.0% during the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after acquiring an additional 139 shares during the period. Silver Oak Securities Incorporated boosted its stake in GE HealthCare Technologies by 4.6% during the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after purchasing an additional 140 shares during the period. Chicago Capital LLC boosted its stake in GE HealthCare Technologies by 2.2% during the 2nd quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after purchasing an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH grew its holdings in GE HealthCare Technologies by 4.2% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after buying an additional 143 shares during the last quarter. Finally, Golden State Wealth Management LLC increased its position in GE HealthCare Technologies by 7.4% in the 2nd quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after buying an additional 148 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on GEHC. Bank of America raised their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Evercore ISI restated an “outperform” rating and issued a $95.00 price target on shares of GE HealthCare Technologies in a research report on Monday, January 5th. The Goldman Sachs Group restated a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Finally, Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Seven analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $89.50.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $87.28 on Monday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The company has a 50-day moving average of $80.30 and a 200-day moving average of $76.73. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a market capitalization of $39.76 billion, a price-to-earnings ratio of 18.03, a PEG ratio of 3.39 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.